y0news
AnalyticsDigestsSourcesTopicsRSSAICrypto

#biotech-ai News & Analysis

4 articles tagged with #biotech-ai. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.

4 articles
AIBullishFortune Crypto · Jun 227/10
🧠

Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies

Insilico Medicine and SK Biopharmaceuticals announced a $2.5B partnership focused on AI-driven drug discovery for neuroimmune therapies, representing a major validation of artificial intelligence applications in pharmaceutical development. The deal underscores growing industry confidence in AI's ability to accelerate drug discovery timelines and reduce development costs.

Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
AIBullishGoogle Research Blog · Sep 117/107
🧠

Smarter nucleic acid design with NucleoBench and AdaBeam

The article introduces NucleoBench and AdaBeam, new tools for advancing nucleic acid design in biotechnology. These AI-powered platforms aim to improve the precision and efficiency of genetic engineering and therapeutic applications.

AINeutralarXiv – CS AI · Jun 96/10
🧠

SNR-ST-Mix: Sample-specific Neighborhood Regression Mixup for Augmented Spatial Transcriptomics Imputation with Deep Neural Network

Researchers introduce SNR-ST-Mix, a data augmentation framework designed specifically for spatial transcriptomics that uses geometry-aware and expression-aware mixing to improve deep neural network performance. The method constrains data interpolation to k-nearest spatial neighbors and weights coefficients by expression similarity, enabling more biologically plausible synthetic training samples that enhance prediction accuracy without architectural changes.

AIBullishArs Technica – AI · May 196/10
🧠

Two AI-based science assistants succeed with drug-retargeting tasks

Two AI-based science assistants have demonstrated success in drug-retargeting tasks, with both tools capable of generating hypotheses and one additionally analyzing relevant data. This advancement showcases AI's growing role in accelerating pharmaceutical research and drug discovery processes.

Two AI-based science assistants succeed with drug-retargeting tasks